All Headlines >>
It will compare current prescription levels with two-year retrospective data to gain an understanding of prescribing behaviour.
It will also look at the proportion of prescriptions that are Highest Priority Critically Important Antimicrobials (HPCIAs).
Individual practice data will then be given to a dedicated AMS representative at each surgery who will be responsible for sharing it with their team - to gain an understanding of their prescribing for these conditions and to review actions which can be taken at practice level.
CPD on antimicrobial stewardship will be given to all practices to encourage responsible antimicrobial usage.
The research project will then capture ongoing data - from August 2024 until July 2025 - to show changes in antimicrobial prescribing.
The research is expected to provide an opportunity to build upon ongoing veterinary antimicrobial stewardship strategies.
This could include: using diagnostics to ensure accurate diagnoses and appropriate treatment plans, informing a change in prescribing behaviour, selecting antimicrobials responsibly, educating pet owners on antimicrobial resistance and using evidence-based guidance.
The clinical research project is being run by Kezia Wareham, Doctor of Philosophy student at Bristol Veterinary School (supervised by Dr Fernando Sanchez-Vizcaino, Dr Emi Barker, Dr Nicola Rooney and Dr Irene Bueno Padilla) and Deb Komianos, Regional Clinical Lead at CVS.
Deb said: “Antimicrobial resistance is one of the top ten global health threats and the figures projected by the WHO for attributable deaths are truly startling.
"To address the development of drug-resistant pathogens requires a One Health approach.
"It is not enough to pay lip service to AMS, we need to be leading the change."
PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.